The latest research analysed data from over 8,000 participants from diverse backgrounds, encompassing a range of ages, genders, and socioeconomic statuses, reflecting the true demographics of individuals commonly diagnosed with type 2 diabetes mellitus
Compounding pharmacies, industry groups, and advocacy organizations continue to challenge various aspects of the regulatory framework
Glucagon-like peptide hormone, or GLP-1, plays a key role
Due to the global opioid crisis, the judicious use of chronic opioids is advised and only after informed decision-making with the patients and with periodic follow-ups to assess efficacy, adverse side effects, compliance, and potential of abuse or misuse